Fluorouracil (5FU) Market is Anticipated to Witness High Growth Owing to Rising

Fluorouracil (5FU) Market

The fluorouracil (5FU) market comprises chemotherapeutic agent used for the treatment of cancer, primarily for colorectal cancer as it suppresses the synthesis of the DNA nucleotide thymidine and RNA synthesis. 5FU has advantages over other chemotherapeutic agents as it exhibits high efficacy against a wide range of cancers including breast, head and neck, gastric, and pancreatic cancer. With rising cases of cancer across the globe, the need for effective chemotherapy drugs has increased considerably.

The global fluorouracil (5FU) market is estimated to be valued at US$ 4.04 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Fluorouracil (5FU) Market Size are Kurihama Medical and Addiction Center, National Hospital Organization Kurihama Medical and Addiction Center, Osaka National Hospital, National Hospital Organization Nagasaki Medical Center, National Hospital Organization Kochi Medical Center, National Center for Mental Health (Nashilgil Hospital), Seoul St. Mary's Hospital, Samsung Medical Center, Yonsei University Health System, Asan Medical Center, Beijing HuiLongGuan Hospital, Peking University Sixth Hospital, Beijing Huilongguan Hospital, Shanghai Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, National Institute of Mental Health and Neurosciences (NIMHANS), All India Institute of Medical Sciences (AIIMS), Tata Memorial Hospital, VIMHANS (Vidyasagar Institute of Mental Health and Neurosciences), Schizophrenia Research Foundation (SCARF), Promises Healthcare (Singapore), The Cabin Chiang Mai (Thailand), The Dawn Medical Rehab and Wellness (Thailand), The Solace Sabah (Malaysia), The Kusnacht Practice (Singapore).

The key opportunities in the fluorouracil (5FU) market include rising demand for chemotherapy drugs in developing economies and increasing adoption of 5FU biosimilars to reduce the treatment costs. Additionally, growing number of clinical trials evaluating the efficacy of 5FU in combination with other drugs is anticipated to present lucrative opportunities.

Globally, the leading market players are focusing on expansion strategies across Asian and Latin American countries. With rapidly increasing patient population and healthcare spending in China and India, Asia Pacific is estimated to be one of the most lucrative markets. Moreover, supportive regulatory environment and healthcare reforms in Brazil and Mexico are positively impacting the uptake of 5FU in Latin American countries.

Market drivers

The key driver for fluorouracil (5FU) market is the rising prevalence of advanced and metastatic cancers worldwide. According to WHO, cancer is leading cause of death globally, accounting for nearly 10 million deaths in 2020. Colon cancer also known as colorectal cancer is third most common cancer type globally.

Market restrain

The major restrain for fluorouracil (5FU) market is its toxic side effects. Being chemotherapy drug, 5FU has significant side effects including severe diarrhea, mouth sores, low blood cell count, hair loss, nausea, vomiting, etc. Its intensive administration through infusion also causes patient non-compliance. Stringent regulations for approval of oncology drugs also restricts market growth.


Segment Analysis
The Fluorouracil (5FU) market is dominated by the colorectal cancer sub segment. Colorectal cancer accounts for over 50% of the total Fluorouracil market share globally. 5FU is one of the first line treatment drugs used either alone or in combination with other therapies like levamisole for treating colorectal cancer. Since colorectal cancer accounts for majority of the cancer cases globally and 5FU has been the standard treatment for over three decades for colorectal cancer, it dominates the Fluorouracil market.

Global Analysis
Regionally, North America dominates the Fluorouracil market currently accounting for over 30% share. This is due to number of factors like rising cases of colorectal cancer, presence of advanced healthcare infrastructure and availability of advanced treatment options in the region. Asia Pacific is the fastest growing region for Fluorouracil market expanding at a CAGR of around 8%. This high growth can be attributed to growing cases of gastrointestinal cancers coupled with improving access to cancer treatment in countries like China, India and Japan. Rising healthcare spending and increased adoption of newer treatment therapies have been driving Fluorouracil market in Asia Pacific region.

Get more insights on Fluorouracil (5FU) Market

Also Read Related Article on Microfluidic Market

Comments

Post a Comment

Popular posts from this blog

The global Blast Resistant and Bulletproof Buildings Market Growth Accelerated by Rising Threats

Image
Blast resistant and bulletproof buildings provide protection against explosions, bomb threats and gunfire. They use composite or alloy materials like ballistic glass, reinforced steel and concrete which reinforce structures and withstand blasts or projectiles. The rising threats of terrorist attacks and military aggressions have increased the demand for such secure buildings for government infrastructures, embassies, military installations and other high-security areas. The global Blast Resistant and Bulletproof Buildings Market is estimated to be valued at US$ 1.28 Mn in 2024 and is expected to exhibit a CAGR of 3.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The demand for blast resistant and bulletproof buildings has risen significantly owing to increasing geopolitical conflicts and threats across the world. Majority of countries are allocating higher defense budgets for construction of secure...
Read more

Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is Anticipated to Witness High Growth Owing to Increasing Business Events

Image
  Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market The Saudi Arabia MICE market refers to meetings, incentives, conferences, and exhibitions which cater to business events in the country. MICE activities help businesses to hold strategy and planning meetings, incentive travel programs, product launches, training seminars, and exhibitions. The events industry helps hotels, airlines, transportation, food & beverage sectors in Saudi Arabia. Growing awareness about MICE and its impact on economy is encouraging businesses to organize more events. The Saudi Vision 2030 aims to diversify economy away from oil and develop tourism and entertainment industries which will further boost the MICE market. The Global Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is estimated to be valued at US$ 2.69 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031. Key Takeaways Key players operating in ...
Read more

Mometasone Furoate Market Poised for High Growth Due to Rising Prevalence of Respiratory Diseases

Image
  Mometasone Furoate Market Mometasone furoate is a corticosteroid used for the treatment and prevention of asthma, allergic rhinitis, nasal polyps, skin diseases and other inflammatory conditions. It is typically administered as an inhaled medication for asthma and as a topical cream or ointment for skin conditions like dermatitis and eczema. Mometasone furoate works by reducing inflammation and helps ease symptoms like wheezing, breathlessness, and itching caused by various inflammatory reactions in the body. The growing prevalence of asthma and other allergic diseases globally has significantly boosted the demand for mometasone furoate based drugs and products. The global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Mil...
Read more